Unlike GLP-1RAs, particularly dulaglutide (254), SGLT-2 inhibitors have not demonstrated cardiovascular benefits in primary prevention among individuals with multiple cardiovascular risk factors (261)
Doses are then gradually escalated, commonly to 4 mg, 8 mg, or up to 12 mg weekly, depending on patient tolerance and weight loss objectives
Drugs that may increase or decrease the blood glucose lowering effect: alcohol, beta-blockers, clonidine, lithium salts, and pentamidine
The procedures include using disposable and sterilized equipment to prevent the occurrence of contamination
Although that guide focuses on GLP-1 prescriptions, its core questions about patient name, prescriber, pharmacy, concentration, dosing, storage, and follow-up also help patients recognize the difference between a real prescription and an unlabeled or mystery vial